Southern RNA manufactures mRNA raw materials and drug substances as a Contract Development and Manufacturing Organization (CDMO), providing essential starting materials for advanced therapy medicinal products (ATMPs) and mRNA vaccines. The company ensures high-quality production through stringent quality control processes, addressing the need for reliable and effective nucleic acid products in the biopharmaceutical industry.
Funding
Funding not disclosed
Founders
Product
Problem
The biopharmaceutical industry requires reliable and high-quality mRNA and plasmid DNA (pDNA) raw materials for advanced therapy medicinal products (ATMPs) and mRNA vaccines. Inconsistent quality and scalability challenges in nucleic acid production can hinder the development and manufacturing of effective therapeutics.
Solution
Southern RNA is a Contract Development and Manufacturing Organization (CDMO) specializing in the production of mRNA and pDNA raw materials and drug substances. They offer end-to-end services from molecular engineering and cell banking to GMP-Start™ grade nucleic acid production, ensuring high-quality starting materials for ATMP and vaccine development. Southern RNA utilizes proprietary production and purification methods to deliver scalable solutions ranging from milligrams to grams, supported by comprehensive analytical testing and quality control. Their services facilitate the development of mRNA-based therapeutics, including vaccines, gene therapies, and CAR-T cell manufacturing, with phase-appropriate documentation and regulatory support.
Target Audience
Southern RNA serves biopharmaceutical companies, vaccine developers, and research institutions requiring high-quality mRNA and pDNA raw materials for preclinical and clinical applications.
Features
- CDMO services for mRNA and plasmid DNA (pDNA) manufacturing
- GMP-Start™ grade materials suitable for ATMP and vaccine development
- Molecular engineering and microbial cell bank production
- Proprietary production and purification methods for high-quality nucleic acids
- Scalable production from milligrams to grams
- Analytical testing services for pDNA, mRNA, and cap analogs
- Assay/method development, qualification, validation, and verification
- Support for stability studies on nucleic acid products